Department of Pediatrics, Weill Cornell Medicine, New York, New York, USA.
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Transfusion. 2021 Jul;61(7):2042-2053. doi: 10.1111/trf.16443. Epub 2021 May 11.
While previous studies have described the use of blood components in subsets of children, such as the critically ill, little is known about transfusion practices in hospitalized children across all departments and diagnostic categories. We sought to describe the utilization of red blood cell, platelet, plasma, and cryoprecipitate transfusions across hospital settings and diagnostic categories in a large cohort of hospitalized children.
The public datasets from 11 US academic and community hospitals that participated in the National Heart Lung and Blood Institute Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) were accessed. All nonbirth inpatient encounters of children 0-18 years of age from 2013 to 2016 were included.
61,770 inpatient encounters from 41,943 unique patients were analyzed. Nine percent of encounters involved the transfusion of at least one blood component. RBC transfusions were most common (7.5%), followed by platelets (3.9%), plasma (2.5%), and cryoprecipitate (0.9%). Children undergoing cardiopulmonary bypass were most likely to be transfused. For the entire cohort, the median (interquartile range) pretransfusion laboratory values were as follows: hemoglobin, 7.9 g/dl (7.1-10.4 g/dl); platelet count, 27 × 10 cells/L (14-54 × 10 cells/L); and international normalized ratio was 1.6 (1.4-2.0). Recipient age differences were observed in the frequency of RBC irradiation (95% in infants, 67% in children, p < .001) and storage duration of RBC transfusions (median storage duration of 12 [8-17] days in infants and 20 [12-29] days in children, p < .001).
Based on a cohort of patients from 2013 to 2016, the transfusion of blood components is relatively common in the care of hospitalized children. The frequency of transfusion across all pediatric hospital settings, especially in children undergoing cardiopulmonary bypass, highlights the opportunities for the development of institutional transfusion guidelines and patient blood management initiatives.
虽然之前的研究已经描述了在某些儿童亚组(如危重症儿童)中使用血液成分的情况,但对于所有科室和诊断类别的住院儿童的输血实践知之甚少。我们试图描述在大型住院儿童队列中,在各个医院环境和诊断类别中使用红细胞、血小板、血浆和冷沉淀的情况。
我们访问了参与国家心肺血液研究所受体流行病学和供体评估研究 III(REDS-III)的 11 家美国学术和社区医院的公共数据集。纳入了 2013 年至 2016 年期间所有非分娩住院患者 0-18 岁的住院患者。
共分析了 41943 名患者的 61770 例住院患者。9%的患者接受了至少一种血液成分的输血。红细胞输血最为常见(7.5%),其次是血小板(3.9%)、血浆(2.5%)和冷沉淀(0.9%)。接受心肺旁路手术的患儿最有可能接受输血。对于整个队列,输血前实验室值的中位数(四分位距)如下:血红蛋白 7.9 g/dl(7.1-10.4 g/dl);血小板计数 27×10 个/L(14-54×10 个/L);国际标准化比值为 1.6(1.4-2.0)。在红细胞照射的频率(婴儿为 95%,儿童为 67%,p<.001)和红细胞输注的储存时间(婴儿为 12[8-17]天,儿童为 20[12-29]天,p<.001)方面,接受者年龄存在差异。
根据 2013 年至 2016 年的患者队列,血液成分的输血在住院儿童的治疗中相对常见。所有儿科医院环境,尤其是心肺旁路手术患儿的输血频率,突出了制定机构输血指南和患者血液管理计划的机会。